Patent regime and historic developments in India for the life sciences sector

By Arshad Jamil

India has a hard-won reputation as a major producer of generic pharmaceuticals. However, the IP framework around life sciences is evolving, prompting changes within the sector

Enter your details below to log into your account.

Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.

Twitter

17 Sep 2021

@IAM_Alerts RT @AMorrisReports: Recent #FTC announcement beefing up investigative powers & targeting alleged #IP abuses signals another Biden administr… Read more

17 Sep 2021

@IAM_Alerts RT @AMorrisReports: This is blowing my mind. 6G??? Sign me up! https://t.co/yM05XY1dDf @IAM_Alerts https://t.co/0iCAh22EQs Read more

17 Sep 2021

@IAM_Alerts $300 million Bausch Health settlement demonstrates the huge sums at stake in reverse payment disputes:… https://t.co/fsfG5fEp4x Read more

16 Sep 2021

@IAM_Alerts RT @AMorrisReports: Qualcomm’s Mark Snyder said this week that the company was attacked in court by an opponent disrespecting the value of… Read more

Patent regime and historic developments in India for the life sciences sector

Returning user?

Want to read more?

TAGS

Twitter